Codagenix Eyes '23 Nasal RSV Vaccine Readout As GSK, Pfizer Set To Establish Lead

Second Cancer Candidate In Pipeline

 
• By Vibha Ravi
Research in progress
Codagenix Has Multiple Vaccine Candidates In The Making • Source: Shutterstock

More from R&D

More from Scrip